SynaptixBio is a biotechnology research company that develops lifesaving therapies for severe leukodystrophies.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"SynaptixBio — Funding & Investors." VCBacked, August 22, 2024, https://www.vcbacked.co/company/synaptixbio. Accessed July 1, 2026.
VCBacked. (2024). SynaptixBio — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/synaptixbio
{{cite web |title=SynaptixBio — Funding & Investors |url=https://www.vcbacked.co/company/synaptixbio |website=VCBacked |access-date=July 1, 2026}}Profile data sourced and verified per the VCBacked methodology. Last funding round dated .